CIK 0000025743
- Non-accelerated filer
- Smaller reporting company
TherapeuticsMD, Inc.
Sign in to watch- Ticker
- TXMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 870233535
- Phone
- +1 561-961-1900
- Business address
- 951 YAMATO ROAD, SUITE 220, BOCA RATON, FL, 33431
- Former names
- AMHN, Inc., CROFF ENTERPRISES INC, CROFF OIL CO
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-09-25 | Milligan John C.K. IV President/Secretary | Sale | −125,000 | $6.78 | $847K | 1,472,419 |
| 2018-09-25 | Milligan John C.K. IV President/Secretary | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −125,000 | 1,657,255 | ||
| 2018-09-21 | Finizio Robert G CEO | Exercise or conversion | +92,000 | $0.10 | $9K | 18,485,559 |
| 2018-09-21 | Finizio Robert G CEO | Sale | −92,000 | $6.67 | $614K | 18,393,559 |
| 2018-09-21 | Finizio Robert G CEO | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −92,000 | 1,104,910 | ||
| 2018-09-20 | Finizio Robert G CEO | Exercise or conversion | +92,000 | $0.10 | $9K | 18,485,559 |
| 2018-09-20 | Finizio Robert G CEO | Sale | −92,000 | $6.58 | $605K | 18,393,559 |
| 2018-09-20 | Finizio Robert G CEO | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −92,000 | 1,196,910 | ||
| 2018-09-13 | Bernick Brian Director | Exercise or conversion | +91,400 | $0.10 | $9K | 6,648,771 |
| 2018-09-13 | Bernick Brian Director | Sale | −91,400 | $6.35 | $580K | 6,557,371 |
| 2018-09-13 | Bernick Brian Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −91,400 | 1,280,110 | ||
| 2018-09-12 | Bernick Brian Director | Exercise or conversion | +91,400 | $0.10 | $9K | 6,648,771 |
| 2018-09-12 | Bernick Brian Director | Sale | −91,400 | $6.26 | $572K | 6,557,371 |
| 2018-09-12 | Bernick Brian Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −91,400 | 1,371,510 | ||
| 2018-09-11 | Milligan John C.K. IV President/Secretary | Exercise or conversion | +125,000 | $0.10 | $13K | 1,597,419 |
| 2018-09-11 | Milligan John C.K. IV President/Secretary | Sale | −125,000 | $6.13 | $766K | 1,472,419 |
| 2018-09-11 | Milligan John C.K. IV President/Secretary | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −125,000 | 1,782,255 | ||
| 2018-09-10 | Milligan John C.K. IV President/Secretary | Exercise or conversion | +125,000 | $0.10 | $13K | 1,597,419 |
| 2018-09-10 | Milligan John C.K. IV President/Secretary | Sale | −125,000 | $6.07 | $758K | 1,472,419 |
| 2018-09-10 | Milligan John C.K. IV President/Secretary | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −125,000 | 1,907,255 |
Page 22 of 24 · 463 trades